6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis

被引:69
作者
Ocio, E. M.
Schop, R. F. J.
Gonzalez, B.
Van Wier, S. A.
Hernandez-Rivas, J. M.
Gutierrez, N. C.
Garcia-Sanz, R.
Moro, M. J.
Aguilera, C.
Hernandez, J.
Xu, R.
Greipp, P. R.
Dispenzieri, A.
Jalal, S. M.
Lacy, M. Q.
Gonzalez-Paz, N.
Gertz, M. A.
San Miguel, J. F.
Fonseca, R.
机构
[1] Hosp Univ Salamanca, Dept Hematol, Salamanca 37007, Spain
[2] Univ Salamanca, Dept Hematol, Ctr Invest Canc, E-37008 Salamanca, Spain
[3] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA
[4] Hosp Virgen Blanca Leon, Dept Hematol, Leon, Spain
[5] Hosp Gen Segovia, Dept Hematol, Segovia, Spain
关键词
DNA deletions; Waldenstrom macroglobulinemia; fluorescence in situ hybridisation; prognostic; 6q deletion;
D O I
10.1111/j.1365-2141.2006.06389.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluorescence in situ hybridisation (FISH) is an effective technique for the cytogenetic analysis of Waldenstrom macroglobulinemia (WM), but the potential impact of molecular cytogenetics on disease evolution and as a prognostic marker is still unknown. Deletion of the long arm of chromosome 6 (6q-) is the most frequent cytogenetic abnormality in WM. This study analysed the prevalence of this aberration in 102 WM patients, and correlated it with disease characteristics. The incidence of 6q21 deletion was 7% by conventional cytogenetics and 34% when analysed by FISH (54% when cytoplasmic immunoglobulin M-FISH was used). Patients with deletion of 6q displayed features of adverse prognosis, such as higher levels of beta 2-microglobulin and monoclonal paraprotein and a greater tendency to display anaemia and hypoalbuminemia. Interestingly, there was a correlation between the presence of 6q deletion and the International Staging System prognostic index (incidence of 6q- among patients stratified in stages 1, 2 and 3 was 24%, 42% and 67% respectively). Those patients diagnosed with smouldering WM who displayed the abnormality showed a trend to an earlier requirement of treatment. Finally, the survival analysis did not show differences between the two groups of patients, probably due to the short
引用
收藏
页码:80 / 86
页数:7
相关论文
共 44 条
  • [1] A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies
    Ahmann, GJ
    Jalal, SM
    Juneau, AL
    Christensen, ER
    Hanson, CA
    Dewald, GW
    Greipp, PR
    [J]. CANCER GENETICS AND CYTOGENETICS, 1998, 101 (01) : 7 - 11
  • [2] Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
    Avet-Loiseau, H
    Facon, T
    Grosbois, B
    Magrangeas, F
    Rapp, MJ
    Harousseau, JL
    Minvielle, S
    Bataille, R
    [J]. BLOOD, 2002, 99 (06) : 2185 - 2191
  • [3] Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia:: A two-institution study
    Björkholm, M
    Johansson, E
    Papamichael, D
    Celsing, F
    Matthews, J
    Lister, TA
    Rohatiner, AZA
    [J]. SEMINARS IN ONCOLOGY, 2003, 30 (02) : 226 - 230
  • [4] Calasanz MJ, 1997, GENE CHROMOSOME CANC, V18, P84, DOI 10.1002/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.3.CO
  • [5] 2-9
  • [6] Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescence in situ hybridization in Waldenstrom's macroglobulinemia:: a single center study of 22 cases
    Chang, H
    Samiee, S
    Li, D
    Patterson, B
    Chen, CI
    Stewart, AK
    [J]. LEUKEMIA, 2004, 18 (06) : 1160 - 1162
  • [7] Chromosome anomalies detected by interphase fluorescence in situ hybridization:: correlation with significant biological features of B-cell chronic lymphocytic leukaemia
    Dewald, GW
    Brockman, SR
    Paternoster, SF
    Bone, ND
    O'Fallon, JR
    Allmer, C
    James, CD
    Jelinek, DF
    Tschumper, RC
    Hanson, CA
    Pruthi, RK
    Witzig, TE
    Call, TG
    Kay, NE
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (02) : 287 - 295
  • [8] The international staging system for multiple myeloma is applicable in symptomatic Waldenstrom's macroglobulinemia
    Dimopoulos, MA
    Gika, D
    Zervas, K
    Kyrtsonis, MC
    Symeonidis, A
    Anagnostopoulos, A
    Bourantas, K
    Matsouka, C
    Pangalis, GA
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (09) : 1809 - 1813
  • [9] Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner, H
    Stilgenbauer, S
    Benner, A
    Leupolt, E
    Kröber, A
    Bullinger, L
    Döhner, K
    Bentz, M
    Lichter, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) : 1910 - 1916
  • [10] PROGNOSTIC FACTORS IN WALDENSTROM MACROGLOBULINEMIA - A REPORT OF 167 CASES
    FACON, T
    BROUILLARD, M
    DUHAMEL, A
    MOREL, P
    SIMON, M
    JOUET, JP
    BAUTERS, F
    FENAUX, P
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (08) : 1553 - 1558